Consensus Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
5.33 ^USD	+7.24%		-10.42%	-58.20%

May. 17	North American Morning Briefing : The "Everything -2-	DJ
May. 16	UBS Downgrades Treace Medical Concepts to Neutral From Buy, Cuts Price Target to $6.50 From $16	MT

Evolution of the average Target Price on Treace Medical Concepts, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a9f4ebbfe7b7842a967c.k0yLEzgMQ54Ys8wyCpSzg3iJ_PH36nD_J8v-CVMRmrs.2HjeRwxVBqli-PsFTNns003WlJWjszzJE4OwRR1h8OTdGfxhS3wIwU3buw~2046b8e124780503e63c583cd1162c3f

Analyst Recommendations on Treace Medical Concepts, Inc.

UBS Downgrades Treace Medical Concepts to Neutral From Buy, Cuts Price Target to $6.50 From $16	May. 16	MT
UBS Adjusts Price Target on Treace Medical Concepts to $16 From $17, Maintains Buy Rating	May. 08	MT
Truist Downgrades Treace Medical Concepts to Hold From Buy, Cuts PT to $7 From $17; Notes Slowing Growth Outlook Amid Rising Competitive Pressures	May. 08	MT
Truist Securities Downgrades Treace Medical Concepts to Hold From Buy, Lowers Price Target to $7 From $17	May. 08	MT
BTIG Downgrades Treace Medical Concepts to Neutral From Buy	May. 08	MT
JPMorgan Downgrades Treace Medical Concepts to Neutral From Overweight, Cuts Price Target to $8 From $15	May. 08	MT
Stifel Downgrades Treace Medical Concepts to Hold From Buy, Cuts Price Target to $6 From $15	May. 08	MT
Truist Securities Adjusts Price Target on Treace Medical Concepts to $16 From $12, Keeps Buy Rating	Dec. 22	MT
UBS Adjusts Price Target on Treace Medical Concepts to $17 From $24, Maintains Buy Rating	Nov. 13	MT
Morgan Stanley Adjusts Price Target on Treace Medical Concepts to $14 From $30, Maintains Overweight Rating	Nov. 13	MT
Truist Adjusts Price Target on Treace Medical Concepts to $12 From $17, Maintains Buy Rating	Nov. 10	MT
UBS Initiates Treace Medical Concepts With Buy Rating, Price Target is $24	23-09-29	MT
BTIG Adjusts Treace Medical Concepts' Price Target to $27.50 From $32, Keeps Buy Rating	23-08-28	MT
Stephens Adjusts Price Target on Treace Medical Concepts to $25 From $27, Keeps Equalweight Rating	23-08-10	MT
Truist Securities Adjusts Price Target on Treace Medical Concepts to $30 From $33, Maintains Buy Rating	23-08-09	MT
Truist Starts Treace Medical Concepts at Buy With $33	23-05-01	MT
BTIG Adjusts Price Target on Treace Medical Concepts to $32 From $29, Maintains Buy Rating	23-04-17	MT
Stephens Starts Treace Medical Concepts at Equalweight With $26 Price Target	23-04-11	MT
Morgan Stanley Adjusts Price Target on Treace Medical Concepts to $30 From $28, Maintains Overweight Rating	23-03-08	MT
Morgan Stanley Adjusts Treace Medical Concepts' Price Target to $28 from $23, Maintains Overweight Rating	22-10-11	MT
BTIG Raises Price Target on Treace Medical Concepts to $28 From $23, Keeps Buy Rating	22-09-21	MT
Stifel Nicolaus Adjusts Treace Medical Concepts Price Target to $27 From $24, Maintains Buy Rating	22-09-21	MT
Stifel Nicolaus Adjusts Price Target for Treace Medical Concepts to $24 From $21, Maintains Buy Rating	22-08-10	MT
Stifel Lowers Treace Medical Concepts' Price Target to $21 From $32, Maintains Buy Rating	22-07-18	MT
Morgan Stanley Lowers Treace Medical Concepts' Price Target to $22 From $26, Maintains Overweight Rating	22-07-15	MT